Empagliflozin in pharma franchise in Karnataka

Empagliflozin in PCD pharma franchise in Itanagar

Empagliflozin in top pharma company in Meerut

Empagliflozin in pcd pharma supplier in Rajkot

Empagliflozin in phama franchise company in India
Empagliflozin in phama distributor in Kalyan-Dombivli

Home/Products /empagliflozin-10mg-tablet

Emplozin 10 Tablet

Composition : Empagliflozin (10mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10x10

Price : ₹375/-

Emplozin 10 Tablet is an antidiabetic medication that belongs to the class of Sodium-Glucose Co-Transporter-2 (SGLT2) inhibitors. It is designed to improve glycemic control in adults with type 2 diabetes mellitus when used alongside proper diet and exercise. Empagliflozin works by blocking glucose reabsorption in the kidneys, which leads to increased glucose excretion through urine, aiding in blood sugar regulation.

In addition to managing blood sugar levels, this medication has demonstrated cardiovascular benefits, including reducing the risk of hospitalization due to heart failure in patients with type 2 diabetes. Emplozin 10 Tablet is also beneficial in lowering blood pressure and contributing to weight management, making it an effective and comprehensive option for diabetes care.

This medication is particularly suited for patients seeking a modern solution to diabetes management that addresses both glycemic control and associated cardiovascular risks. It should be used under the supervision of a healthcare provider and as part of a holistic approach to diabetes care.

Read More

About the Product

Emplozin 10 Tablet is an antidiabetic medication that belongs to the class of Sodium-Glucose Co-Transporter-2 (SGLT2) inhibitors. It is designed to improve glycemic control in adults with type 2 diabetes mellitus when used alongside proper diet and exercise. Empagliflozin works by blocking glucose reabsorption in the kidneys, which leads to increased glucose excretion through urine, aiding in blood sugar regulation.

In addition to managing blood sugar levels, this medication has demonstrated cardiovascular benefits, including reducing the risk of hospitalization due to heart failure in patients with type 2 diabetes. Emplozin 10 Tablet is also beneficial in lowering blood pressure and contributing to weight management, making it an effective and comprehensive option for diabetes care.

This medication is particularly suited for patients seeking a modern solution to diabetes management that addresses both glycemic control and associated cardiovascular risks. It should be used under the supervision of a healthcare provider and as part of a holistic approach to diabetes care.

Common side effects include frequent urination, urinary tract infections, genital infections, and mild dehydration. Rare but serious side effects include diabetic ketoacidosis and severe genital infections.

Emplozin 10 Tablet is indicated for the management of type 2 diabetes mellitus as an adjunct to diet and exercise. It may also help reduce the risk of hospitalization for heart failure in patients with type 2 diabetes.

This medication is not intended for type 1 diabetes or diabetic ketoacidosis. Follow your doctor’s instructions and report any unusual symptoms promptly.

Store in a cool, dry place below 30°C. Protect from light and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation